James D. Neaton
University of Minnesota
2 papers in the Anchorcite directory, published between 2003 and 2020, cited 12,510 times in total.
ORCID profileResearch topics
- SARS-CoV-2 and COVID-19 Research · 1 paper
- COVID-19 Clinical Research Studies · 1 paper
- Respiratory Support and Mechanisms · 1 paper
- Renin-Angiotensin System Studies · 1 paper
- Heart Failure Treatment and Management · 1 paper
- Hormonal Regulation and Hypertension · 1 paper
Frequent co-authors
- John H. Beigel · 1 paper
- Kay M Tomashek · 1 paper
- Lori Elizabeth Dodd · 1 paper
- Aneesh K. Mehta · 1 paper
- Barry S. Zingman · 1 paper
- André C. Kalil · 1 paper
- Elizabeth L. Hohmann · 1 paper
- Helen Y. Chu · 1 paper
Papers
- Remdesivir for the Treatment of Covid-19 — Final ReportNew England Journal of Medicine · 2020 · 7,417 citations
BACKGROUND: Although several therapeutic agents have been evaluated for the treatment of coronavirus disease 2019 (Covid-19), no antiviral agents have yet been shown to be efficacious. METHODS: We conducted a double-blind, randomized, placebo-controlled trial of intravenous remdesivir in adults who…
- Eplerenone, a Selective Aldosterone Blocker, in Patients with Left Ventricular Dysfunction after Myocardial InfarctionNew England Journal of Medicine · 2003 · 5,093 citations
BACKGROUND: Aldosterone blockade reduces mortality and morbidity among patients with severe heart failure. We conducted a double-blind, placebo-controlled study evaluating the effect of eplerenone, a selective aldosterone blocker, on morbidity and mortality among patients with acute myocardial infarction complicated by…
Metadata from OpenAlex (CC0).